Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
05.08.25
/
50%
€344.35
Target price
05.08.26
€478.40
Performance (%)
8.51%
Price
13.11.25
€373.65
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 8.51%. This prediction currently runs until 05.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.208% | 3.208% |
| iShares Core DAX® | 1.408% | 0.847% |
| iShares Nasdaq 100 | -1.283% | 5.518% |
| iShares Nikkei 225® | -1.836% | 8.828% |
| iShares S&P 500 | -0.028% | 4.858% |
Comments by UBS_Group_AG for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at UBS Group AG from $582.00 to $553.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€352.60
07.11.25
07.11.25
€473.22
07.11.26
07.11.26
5.97%
13.11.25
13.11.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.85
05.11.24
05.11.24
€536.01
05.11.25
05.11.25
-21.69%
06.11.25
06.11.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.95
17.10.24
17.10.24
€519.06
17.10.25
17.10.25
-21.84%
18.10.25
18.10.25